Prostatic Size Reduction Following of Leuprorelin Acetate
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-95
SponsorConsorci Sanitari de Terrassa
About this trial
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
prostate Cancer patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
ACETATE LEUPRELINE
Other interventionUSE ACETATE LEUPRELINE BEFORE AND AFTER PROSTATE DELIMITATION
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: prostate patient1 intervention
Trial outcomes
Primary outcomes
1
prostate size change
comparative size between pre and post Leupreline treatment
Time frame
at 2 months of leuprelineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov